Status:

COMPLETED

Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)

Lead Sponsor:

Weill Medical College of Cornell University

Collaborating Sponsors:

Biotronik, Inc.

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18+ years

Brief Summary

The primary aim of the "Sensing Atrial High Rate Episodes with DX System in Implantable Cardioverter Defibrillators Trial" (SENSE Trial) is to assess the efficacy of a implantable cardioverter-defibri...

Detailed Description

The SENSE Trial is designed to study the efficacy of the DX System in detection of atrial high rate episodes (AHREs) in subjects with no prior history of atrial fibrillation. The DX System, or "DX," c...

Eligibility Criteria

Inclusion

  • Fulfills standard indications for ICD implantation
  • Subject or legally authorized representative can provide written authorization per institutional requirements
  • Subject is intended to be implanted with a complete Biotronik DX system (consisting of a Biotronik Ilesto 7 VR-T DX ICD or any future FDA approved Lumax VR-T DX ICD, and the Biotronik Linox Smart S DX lead), or has been implanted with a complete Biotronik DX system no more than 30 days prior to the date of consent
  • Able to comply with Home Monitoring

Exclusion

  • Subject has prior diagnosis of atrial fibrillation or atrial flutter
  • Subject has need for atrial pacing
  • Subject unwilling or unable to give informed consent or participate in follow-up
  • Subject is unable to comply with Home Monitoring
  • Subject is pregnant
  • Subject has less than one year estimated life expectancy
  • Subject was implanted with a cardiac device capable of detecting AHREs prior to implantation of the Biotronik DX system
  • Subject was implanted with Biotronik DX system and had an AHRE detection before enrollment

Key Trial Info

Start Date :

July 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2018

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT02186704

Start Date

July 1 2014

End Date

July 1 2018

Last Update

August 28 2018

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

2

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

3

Weill Cornell Medical College

New York, New York, United States, 10021

4

Westchester Medical Center

Valhalla, New York, United States, 10532